News for hackers. Stuff that matters.
Re:GlaxoSmithKline makes $300M investment in 23andMe, forms ... by gbrown on Wednesday July 25, 2018 @02:12PM (#17611424)
Another worry is that there are already lots of companies willing to sell predictive indices for consumers. I could easily imagine "data laundering" where the genetic information is condensed, along with other social and demographic information, into risk indices which are not obviously labeled as containing genetic data. If an insurance company uses a vended solution like this, it would be harder to trace, and may introduce legal complications.

There are no comments on this comment yet.